05.11.19 | Vollzeit | Zug | headcount AGtreatment therapies. Their industry-leading antibody-drug conjugate (ADC) technology harnesses antibodies' specificity to administer direct and targeted oncotoxin treatments. In addition to their main marketed product, they are advancing a promising product pipeline of other novel oncotherapies for both
Später ansehen31.10.19 | Vollzeit | Zug | headcount AGAntibodies' specifity to administer direct and targeted oncotoxin treatments. In addition to their main marketed product, they are advancing a promising product pipeline of other novel
Später ansehenVerpassen Sie nie wieder einen passenden Job!
Alle Jobs für Process Treatment in Zug kostenlos abonnieren.